• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


Germany-Based Evotec Opens U.S. Headquarters In Princeton, New Jersey

Evotec AG, a global drug discovery alliance and development partnership company headquartered in Hamburg, Germany, opened its United States headquarters and expanded facility in Princeton, New Jersey.

“Princeton is an ideal location for our headquarters based on its proximity to many of the world’s leading biopharmaceutical and Pharma companies and universities, as well as its experienced talent pool that has knowledge and expertise in drug discovery,” said Dr. Werner Lanthaler CEO of Evotec AG. “Our Princeton location puts us in easy reach of many our alliance and development partners and gives us the opportunity to cultivate new partnerships in the U.S.”

Evotec established its Princeton office in 2015 and currently employs a team of more than 20 employees. The 20,000-square-foot expanded facility accommodates additional laboratory and office space for its growing operations in New Jersey.

“We are excited that Evotec chose New Jersey for its U.S. headquarters and look forward to working with the company as it continues to expand its operations in Princeton,” said Michele Brown, President & CEO of Choose New Jersey, Inc. “The company’s focus on innovative drug discovery has made it a welcome addition to our State’s biopharmaceutical ecosystem.”

Choose New Jersey, a privately-funded non-profit organization charged with encouraging and nurturing economic growth throughout the State, and BioNJ, the New Jersey affiliate of BIO International provided assistance to Evotec to ensure the successful establishment of its U.S. headquarters and facility expansion in New Jersey.


Exclusive Research